Therefore, the quantification of the percentage of non-suppressive T cells is likely to help clarify the clinical relevance of FOXp3+ in CCA and reduce the limitation in this study, although further investigations are necessary for clarification. This evidence concerns the gene FOXP3 and cholangiocarcinoma.